Related Experiment Videos
Interphase cytogenetics of brain tumors.
E P Arnoldus1, I A Noordermeer, A C Peters
1Department of Neurology, Leiden University, The Netherlands.
Genes, Chromosomes & Cancer
|March 1, 1991
Summary
Interphase cytogenetics successfully analyzes brain tumor chromosomal aberrations using in situ hybridization. This method overcomes challenges in obtaining metaphases, aiding in solid tumor genetic diagnosis.
Area of Science:
- Oncology
- Genetics
- Cytogenetics
Background:
- Conventional cytogenetics for solid tumors is often limited by poor quality metaphase spreads.
- Interphase cytogenetics offers an alternative approach for analyzing chromosomal abnormalities.
Purpose of the Study:
- To develop and apply a method for interphase cytogenetics on brain tumor samples.
- To identify numerical chromosomal aberrations in gliomas and meningiomas.
Main Methods:
- Nuclei from fresh brain tumor tissue were analyzed using nonradioactive in situ hybridization.
- A panel of nine chromosome-specific satellite DNA probes and a BCR gene cosmid probe were utilized.
- Hybridization signals were quantified in 200 nuclei per probe to detect numerical aberrations.
Main Results:
- Gliomas showed gains (chromosomes 1, 7, 10, 11, X) and losses (chromosomes 1, 10, 17, Y), with one case of tetraploidy.
- Meningiomas exhibited monosomy 18, trisomy 17, and monosomy 22q (BCR gene locus).
Conclusions:
- Interphase cytogenetics is valuable for analyzing solid tumors, particularly when conventional cytogenetics is challenging.
- This technique facilitates the detection of numerical chromosomal aberrations in brain tumors.